Correlation Between Willamette Valley and Raphael Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Willamette Valley and Raphael Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Willamette Valley and Raphael Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Willamette Valley Vineyards and Raphael Pharmaceutical, you can compare the effects of market volatilities on Willamette Valley and Raphael Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Willamette Valley with a short position of Raphael Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Willamette Valley and Raphael Pharmaceutical.
Diversification Opportunities for Willamette Valley and Raphael Pharmaceutical
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Willamette and Raphael is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Willamette Valley Vineyards and Raphael Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Raphael Pharmaceutical and Willamette Valley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Willamette Valley Vineyards are associated (or correlated) with Raphael Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Raphael Pharmaceutical has no effect on the direction of Willamette Valley i.e., Willamette Valley and Raphael Pharmaceutical go up and down completely randomly.
Pair Corralation between Willamette Valley and Raphael Pharmaceutical
Given the investment horizon of 90 days Willamette Valley Vineyards is expected to generate 0.16 times more return on investment than Raphael Pharmaceutical. However, Willamette Valley Vineyards is 6.17 times less risky than Raphael Pharmaceutical. It trades about -0.05 of its potential returns per unit of risk. Raphael Pharmaceutical is currently generating about -0.13 per unit of risk. If you would invest 351.00 in Willamette Valley Vineyards on September 14, 2024 and sell it today you would lose (22.00) from holding Willamette Valley Vineyards or give up 6.27% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.44% |
Values | Daily Returns |
Willamette Valley Vineyards vs. Raphael Pharmaceutical
Performance |
Timeline |
Willamette Valley |
Raphael Pharmaceutical |
Willamette Valley and Raphael Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Willamette Valley and Raphael Pharmaceutical
The main advantage of trading using opposite Willamette Valley and Raphael Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Willamette Valley position performs unexpectedly, Raphael Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Raphael Pharmaceutical will offset losses from the drop in Raphael Pharmaceutical's long position.Willamette Valley vs. Naked Wines plc | Willamette Valley vs. Andrew Peller Limited | Willamette Valley vs. Iconic Brands | Willamette Valley vs. Naked Wines plc |
Raphael Pharmaceutical vs. Amkor Technology | Raphael Pharmaceutical vs. Reservoir Media | Raphael Pharmaceutical vs. Valens | Raphael Pharmaceutical vs. Plexus Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |